Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems

作者: Andreia Granja , Iúri Frias , Ana Rute Neves , Marina Pinheiro , Salette Reis

DOI: 10.1155/2017/5813793

关键词: PharmacologyPopulationNanocarriersDiabetes mellitusEpigallocatechin gallateMedicine

摘要: Nowadays, the society is facing a large health problem with rising of new diseases, including cancer, heart diabetes, neurodegenerative and obesity. Thus, it important to invest in substances that enhance population. In this context, epigallocatechin gallate (EGCG) flavonoid found many plants, especially tea. Several studies support notion EGCG has several benefits fighting obesity, among others. Nevertheless, poor intestinal absorbance instability constitute main drawback use molecule prevention therapy. The encapsulation nanocarriers leads its enhanced stability higher therapeutic effects. A comprehensive review currently available on by means will be addressed.

参考文章(140)
Peter C?H Hollman, Ilja C?W Arts, Flavonols, flavones and flavanols: nature, occurrence and dietary burden Journal of the Science of Food and Agriculture. ,vol. 80, pp. 1081- 1093 ,(2000) , 10.1002/(SICI)1097-0010(20000515)80:7<1081::AID-JSFA566>3.0.CO;2-G
Samuel Legeay, Marion Rodier, Laetitia Fillon, Sébastien Faure, Nicolas Clere, Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome Nutrients. ,vol. 7, pp. 5443- 5468 ,(2015) , 10.3390/NU7075230
TAKEHITO MARUYAMA, SOICHIRO MURATA, KEN NAKAYAMA, NAOKI SANO, KOICHI OGAWA, TAKESHI NOWATARI, TAKAFUMI TAMURA, REIJI NOZAKI, KIYOSHI FUKUNAGA, NOBUHIRO OHKOHCHI, (-)-Epigallocatechin-3-gallate suppresses liver metastasis of human colorectal cancer Oncology Reports. ,vol. 31, pp. 625- 633 ,(2014) , 10.3892/OR.2013.2925
Rainer H Müller, Karsten Mäder, Sven Gohla, Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics. ,vol. 50, pp. 161- 177 ,(2000) , 10.1016/S0939-6411(00)00087-4
Matthew A.C. Zapf, Anai N. Kothari, Cynthia E. Weber, Matthew L. Arffa, Phillip Y. Wai, Joseph Driver, Gopal N. Gupta, Paul C. Kuo, Zhiyong Mi, Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma. Surgery. ,vol. 158, pp. 1039- 1048 ,(2015) , 10.1016/J.SURG.2015.06.011
J Steinmann, J Buer, T Pietschmann, E Steinmann, Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. British Journal of Pharmacology. ,vol. 168, pp. 1059- 1073 ,(2013) , 10.1111/BPH.12009
Dominic J. Withers, Julio Sanchez Gutierrez, Heather Towery, Deborah J. Burks, Jian-Ming Ren, Stephen Previs, Yitao Zhang, Dolores Bernal, Sebastian Pons, Gerald I. Shulman, Susan Bonner-Weir, Morris F. White, Disruption of IRS-2 causes type 2 diabetes in mice Nature. ,vol. 391, pp. 900- 904 ,(1998) , 10.1038/36116
Kiran S Avadhani, Jyothsna Manikkath, Mradul Tiwari, Misra Chandrasekhar, Ashok Godavarthi, Shimoga M Vidya, Raghu C Hariharapura, Guruprasad Kalthur, Nayanabhirama Udupa, Srinivas Mutalik, None, Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage. Drug Delivery. ,vol. 24, pp. 61- 74 ,(2017) , 10.1080/10717544.2016.1228718
Yuting Fan, Yuzhu Zhang, Wallace Yokoyama, Jiang Yi, None, β-Lactoglobulin–chlorogenic acid conjugate-based nanoparticles for delivery of (−)-epigallocatechin-3-gallate RSC Advances. ,vol. 7, pp. 21366- 21374 ,(2017) , 10.1039/C6RA28462K